MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

Charlie Lee and GSR acted as lead investors, alongside participation from the Litecoin Foundation and prominent crypto ...

A little-known Nasdaq-listed drugmaker plans to invest $100M in litecoin, appoints Charlie Lee to its board and names GSR as ...

MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group ...

Attention remains on large-cap tokens on Friday as crypto bills’ approval fueled crypto rallies. While Ethereum steadied ...

MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...

MEI Pharma has taken a major step, becoming the first publicly traded firm on a national exchange to include Litecoin (LTC) as a major treasury reserve asset. Starting with a $100 million private ...

MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond ...

MEI Pharma ( (MEIP)) has issued an update. On July 17, 2025, MEI Pharma entered into securities purchase agreements for a private placement offering, raising approximately $100 million to initiate a ...

Tracing the weekly technical analysis, Litecoin has broken through the 55-EMA and 200-EMA—two indicators often used by medium ...

Litecoin price prediction chatter has returned with force after LTC surged 23% in a single day, hitting $119, its highest ...

How companies like MicroStrategy and SharpLink are using crypto treasury strategies to reshape corporate finance with bitcoin ...